Quantcast
Latest Stories

Lilly drug chosen for Alzheimer’s prevention study

By

Dr. Reisa Sperling, director of the Alzheimer’s center at Brigham and Women’s Hospital in Boston. www.brighamandwomens.org

Researchers have chosen an experimental drug by Eli Lilly & Co. for a large federally funded study testing whether it’s possible to prevent Alzheimer’s disease in older people at high risk of developing it.

The drug, called solanezumab, is designed to bind to and help clear the sticky deposits that clog patients’ brains.

Earlier studies found it did not help people with moderate to severe Alzheimer’s but it showed some promise against milder disease. Researchers think it might work better if given before symptoms start.

“The hope is we can catch people before they decline,” which can come 10 years or more after plaques first show up in the brain, said Dr. Reisa Sperling, director of the Alzheimer’s center at Brigham and Women’s Hospital in Boston.

She will help lead the new study, which will involve 1,000 people ages 70 to 85 whose brain scans show plaque buildup but who do not yet have any symptoms of dementia. They will get monthly infusions of solanezumab or a dummy drug for three years. The main goal will be slowing the rate of cognitive decline. The study will be done at 50 sites in the U.S. and possibly more in Canada, Australia and Europe, Sperling said.

In October, researchers said combined results from two studies of solanezumab suggested it might modestly slow mental decline, especially in patients with mild disease. Taken separately, the studies missed their main goals of significantly slowing the mind-robbing disease or improving activities of daily living.

Those results were not considered good enough to win the drug approval. So in December, Lilly said it would start another large study of it this year to try to confirm the hopeful results seen patients with mild disease. That is separate from the federal study Sperling will head.

About 35 million people worldwide have dementia, and Alzheimer’s is the most common type. In the U.S., about 5 million have Alzheimer’s. Current medicines such as Aricept and Namenda just temporarily ease symptoms. There is no known cure.


Follow Us


Follow us on Facebook Follow on Twitter Follow on Twitter


Recent Stories:

Complete stories on our Digital Edition newsstand for tablets, netbooks and mobile phones; 14-issue free trial. About to step out? Get breaking alerts on your mobile.phone. Text ON INQ BREAKING to 4467, for Globe, Smart and Sun subscribers in the Philippines.

Tags: Alzheimer , Drugs , Eli Lilly & Co. , Health , Lilly Drug , Medicine , mental health , wellness



Copyright © 2014, .
To subscribe to the Philippine Daily Inquirer newspaper in the Philippines, call +63 2 896-6000 for Metro Manila and Metro Cebu or email your subscription request here.
Factual errors? Contact the Philippine Daily Inquirer's day desk. Believe this article violates journalistic ethics? Contact the Inquirer's Reader's Advocate. Or write The Readers' Advocate:
c/o Philippine Daily Inquirer Chino Roces Avenue corner Yague and Mascardo Streets, Makati City, Metro Manila, Philippines Or fax nos. +63 2 8974793 to 94
Advertisement
  1. How to enjoy Buntod
  2. Life lessons I want to teach my son
  3. Kim Atienza: At home with art and design
  4. ‘Wild West’ Masbate’s pristine marine gems
  5. How Zsa Zsa Padilla found Conrad Onglao; Sharon Cuneta played Cupid
  6. Sweet party for Andi Manzano
  7. Haneda International Airport: A destination on its own
  8. Historic Fort Bonifacio tunnel converted into a septic tank
  9. Entering the monkhood a rite of passage
  10. How Margie Moran-Floirendo keeps her dancer’s body
  1. How Zsa Zsa Padilla found Conrad Onglao; Sharon Cuneta played Cupid
  2. Are your favorite malls open this Holy Week break?
  3. Historic Fort Bonifacio tunnel converted into a septic tank
  4. ‘Labahita a la bacalao’
  5. Miss America: Don’t suspend teen over prom invite
  6. How Margie Moran-Floirendo keeps her dancer’s body
  7. This is not just a farm
  8. President Quezon was born here–and so was Philippine surfing
  9. Levine designs womenswear with help from fiancee
  10. Clams and garlic, softshell crab risotto–not your usual seafood fare for Holy Week
  1. How Zsa Zsa Padilla found Conrad Onglao; Sharon Cuneta played Cupid
  2. Mary Jean Lastimosa is new Miss Universe Philippines
  3. Did Angara ruin Pia Wurtzbach’s chances at Bb. Pilipinas?
  4. Dominique–Gretchen and Tonyboy Cojuangco’s daughter–now an endorser
  5. Vinegar test helpful vs cervical cancer
  6. From Jeannie to mom of suicide victim
  7. San Vicente beaches hidden but not for long
  8. Borgy and Georgina are back; others are off–again
  9. Why is the lifestyle set now afraid to wear jewelry–before Kim Henares?
  10. Sen. Angara: I thought Pia Wurtzbach gave a good answer

News

  • Camilla’s brother dies in US after head injury
  • Luisita farmers storm DAR compound
  • Trillanes, Ejercito confident they are not in Napoles’ list
  • Easterlies to prevail in Luzon, Visayas
  • Lacson eyes P106-B ‘Yolanda’ rehab masterplan
  • Sports

  • Phelps having fun in his return to swimming
  • Murray breaks down in tears at Scottish ceremony
  • Mixers trim Aces; Painters repulse Bolts
  • Donaire junks Garcia as coach, taps father
  • ’Bye Ginebra: No heavy heart this time
  • Lifestyle

  • Photos explore dynamics of youths’ sexual identity
  • 12th Philippine Food Expo set at the World Trade Center
  • No tourist draw, Malang the croc will remain wild
  • The best flavors of summer in one bite, and more
  • Homemade yogurt, bread blended with pizza, even ramen
  • Entertainment

  • Sony developing live-action Barbie comedy
  • California court won’t review Jackson doctor case
  • Return of ‘Ibong Adarna’
  • Practical Phytos plans his future
  • In love … with acting
  • Business

  • Facebook profits triple as mobile soars
  • Insular Honors Sales Performers at Testimonial Rites
  • Apple increases stock buyback, will split stock
  • Cost-recovery provisions for affected gencos urged
  • This time, BIR goes after florists
  • Technology

  • Top Traits of Digital Marketers
  • No truth to viral no-visa ‘chronicles’
  • ‘Unlimited’ Internet promos not really limitless; lawmakers call for probe
  • Viber releases new design for iPhone, comes to Blackberry 10 for the first time
  • Engineers create a world of difference
  • Opinion

  • Editorial cartoon, April 24, 2014
  • Talking to Janet
  • Respite
  • Bucket list
  • JPII in 1981: walking a tightrope
  • Global Nation

  • Filipinos in Middle East urged to get clearance before returning
  • PH seeks ‘clearer assurance’ from US
  • China and rivals sign naval pact to ease maritime tensions
  • What Went Before: Manila bus hostage crisis
  • Obama arrives in Tokyo, first stop of 4-nation tour
    Marketplace